Transforming Biopharma Manufacturing by 2030: Harnessing Agentic AI for Cost-Effective Process Innovation

Sanat Chattopadhyay
Executive Vice President & President, Merck Manufacturing Division
Merck

In this forward-looking keynote session at the Biomanufacturing World Summit (BMWS), Sanat Chattopadhyay, Executive Vice President & President of the Merck Manufacturing Division, shares how agentic AI is poised to transform biopharma manufacturing by 2030.

This session highlights the future of intelligent, cost-efficient production and the strategic capabilities needed to prepare for the next era of biomanufacturing innovation.